Background/Aims: Cerebral aneurysm growth is characterized by continuous structural weakness of local smooth muscle cells, though the mechanism is unclear. In this study, we examine protein changes in cerebral aneurysm and human brain vascular smooth muscle cells after cyclic mechanical stretch. We further explore the relationship between the smooth muscle cell changes and reductions in the levels of collagen types IV and VI. Methods: Saccular cerebral aneurysms (n=10) were collected, and temporal artery samples were used as controls. Quantitative proteomics were analyzed and histopathological changes were examined. Smooth muscle cells were cultured in a flexible silicone chamber and subjected to 15% cyclic mechanical stretch. The effect of stretch on the cell viability, function, gene and protein expression were further studied for the understanding the molecular mechanism of aneurysm development. Results: Proteomics analysis revealed 92 proteins with increased expression and 88 proteins with decreased expression compared to the controls (p<0.05). KEGG pathway analysis showed that the change in focal adhesion and extracellular matrix-receptor interaction, suggesting the involvement of collagen type IV and VI. The aneurysm tissue exhibited fewer smooth muscle cells and lower levels of collagen type IV and VI. Human brain vascular smooth muscle cell culture showed spindle-like cells and obvious smooth muscle cell layer. Cell proteomics analysis showed that decreased expression of 118 proteins and increased expression of 32 proteins in smooth muscle cells after cyclic mechanical stretch. KEGG pathway analysis indicated that focal adhesion and ECM-receptor interaction were involved. After cyclic mechanical stretch, collagen type IV and IV expression were decreased. Moreover, the stretch induced MMP-1 and MMP-3 expression elevation. Conclusion: We demonstrated that collagen type IV and VI were decreased in cerebral aneurysms and continuous cyclic mechanical stretch induced smooth muscle cell changes. Smooth muscle cell protection provides an additional therapeutic option to prevent the growth of cerebral aneurysms.
Introduction
Cerebral aneurysms are the main cause of subarachnoid hemorrhage. Un-ruptured cerebral aneurysms occur in 2%-8% of adults [1, 2] . Although the 1-year risk of aneurysms rupture is only 1.4% and the 5-year risk is 3.4% [3] , the morbidity and mortality of cerebral aneurysm growth and rupture are not negligible. During follow-up, the risk of rupture was 12-fold higher in aneurysms with growth than in those without growth [4] .
Prior clinical investigations have identified risk factors for the aneurysm growth, including increased aneurysm size, posterior circulatory location, irregular aneurysm shape, hypertension, cigarette smoking, and gender [3, 4] . Although an aneurysm could be detected incidentally, not all aneurysms require treatment. Many sporadic cerebral aneurysms never rupture [5] . The risk of treatment should be weighed carefully against the risk of aneurysm growth and rupture. Although the molecular and cellular mechanism regarding cerebral aneurysm growth are unclear, previous studies have suggested that cyclic mechanical stretch (CMS) of vessel walls contributed to changes in the vascular structure and smooth muscle cells that were thought to be related to aneurysm growth [6, 7] .
We hypothesized that increased CMS would induce smooth muscle cell structure and functional changes and negatively impacts cerebral aneurysm progression. In this study, we compared the protein changes in aneurysms and superficial temporal arteries (STAs) using semi-quantitative proteomics analysis and found an obvious decrease in the expression of collagen types IV and VI, which determine vascular structure and strength. Human brain vascular smooth muscle cells (HBVSMCs) were subjected to pulsatile CMS to induce cell stretch in aneurysms [8] . We explored changes in HBVSMC viability, migration and protein expression in vitro.
Materials and Methods
The study was examined and approved by the Ethics Committee of Huashan Hospital, Fudan University. Ten aneurysms and ten STA samples were collected. Five samples from each group were randomly chosen for the comparative proteomic analysis or for the histology. After hematoxylin and eosin (HE) and Masson's trichrome staining, an immunohistochemistry was performed to evaluate the expression of collagen types IV and VI. HBVSMCs were cultured in vitro on flexible silicone chambers and subjected to 15% cyclic stretch (ShellPA stretch system, Menicon Life Science) at 60 Hz. The viability of the cyclic mechanical stretch-induced cells was tested with cell counting . Cell migratory function was tested with a transwell assay. The protein changes were analyzed using comparative proteomic analysis. Collagen types IV and VI expression was verified by quantitative polymerase chain reaction (qPCR). The changes in matrix metallopeptidase (MMP)-1 and MMP-3 expression were verified by qPCR and Western blotting.
Detailed methods are described (for all online suppl. material, see www.karger.com/ doi/10.1159/000487347) in the online supplemental data.
Statistical analysis
The statistical analysis was performed with IBM SPSS, and the graphs were generated with GraphPad Prism. Independent sample t-tests were used to analyze the absorbance in the CCK-8 assay, the number of cells in the transwell assay, the percentages of cells in the apoptosis assay, the mRNA expression 
Results

Identification of differentially expressed proteins in aneurysms and STAs
A total of 5 paired aneurysms and STA tissue samples (see online suppl. material, Suppl. Table 1 , 2) were analyzed in the initial discovery phase. The same amounts of protein from each tissue were digested. Then, the peptides were analyzed by nano-liquid chromatographytandem mass spectrometry (N-LC-MS/MS). Using MaxQuant (version 1.3.0.5), we identified 1908 non-redundant proteins with a local false discovery rate (FDR) < 1% and at least two unique peptides per protein. The LFQ (label-free quantification) intensity ratios were calculated for the 1908 proteins, and significant differences in the protein expression levels between the two tissues were determined using t-tests (p < 0.05). Among the 180 proteins that exhibited significant differences, 92 proteins had significant decreased levels and 88 proteins had significantly increased levels in the aneurysm and samples compared to the STA tissue.
We used the online tool DAVID (https://david.ncifcrf.gov/)to identify pathways enriched in the 180 differentially expressed proteins. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the differentially expressed proteins between the aneurysms and STA tissues revealed some vascular-related pathways, including focal adhesion and extracellular matrix (ECM)-receptor interactions (Fig. 1) . Collagen types IV and VI are involved in these two pathways (Table 1) .
Pathology changes in aneurysms patients HE-and Masson's trichromestained sections were examined under low magnification. The STA sections showed obvious vascular structures and a more integrated smooth muscle cell (SMC)arrangement. The SMCs were sparser in the aneurysm sections than in the STA samples. Cell loss and asymmetrical collagen distributions were observed in the aneurysm sections. More collagen type IV + and collagen type VI + were detected via immunohistochemistry in the vascular tunica media, and most of the collagen was located around the SMCs. In the aneurysm tissues, the detection of collagen types IV and VI was rare (Fig. 2) .
SMC identification and CMSinduced functional changes
The HBVSMCs were stained to detect alpha-smooth muscle actin (α-SMA). The cells appeared spindle-like and showed multi-cell processes. All cells were α-SMA positive (Fig. 3A) . The cells were analyzed using the CCK8 kit, and the absorbance of the SMCs in each well was recorded. A significant decrease in absorbance was observed 12, 24, 48 and 72h after CMS, indicating that CMS reduced SMC viability; this was most noticeable at 72h (Fig. 3B) . The transwell invasion assay demonstrated that 15% CMS for72 h reduced the invasive capacity of SMCs (Fig. 3C) . Although 15% CMS for72 h promoted SMC apoptosis, the percentage of apoptotic cells was not significantly different (Fig. 3D) .
Identification of significantly up-regulated and down-regulated proteins in SMCs post-CMS
Three paired SMCs and cells subjected to15% CMS for 72 h were digested and analyzed viaN-LC-MS/MS. Using MaxQuant (version 1.3.0.5), we identified a total of 1037 nonredundant proteins with a local FDR < 1% and at least 2 unique peptides per protein. LFQ intensity ratios were calculated for the 1037 proteins, and significant differences in the protein expression levels between the two groups of cells were determined using a t-tests (p< 0.05). Among the 150 proteins that exhibited significant differences, 118 proteins had significantly decreased levels and 32 proteins had significantly increased levels in the SMCs subjected to CMS compared to the control cells. (Fig. 4A) . We also conducted a protein-protein interaction analysis and found significant protein-protein interactions among these 150 dysregulated proteins (Fig. 4B) . The KEGG pathway analysis of these differentially expressed proteins also demonstrated related pathways, including focal adhesion and ECM-receptor interactions (Fig. 4C) .
CMS reduced the expression of SMC collagen types IV and type VI
Changes in collagen levels in the HBVSMCs subjected to15% CMS for 72 h were investigated. The results indicated that the expression of collagen types IV and VI was downregulated (Fig. 4D) . 
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Discussion
The triggers for aneurysm formation seem to include flow shear stress-induced or inflammation-induced endothelial cell dysfunction and elastic lamina impairment [9] [10] [11] . We identified hemodynamic factors associated with intracranial aneurysm growth and rupture during aneurysm progression after primary impairment of the vascular wall. Hemodynamic factors interact with the aneurysm wall through wall shear stress and blood pressure. Pressure creates tensile stresses in the wall, which are felt by vascular mural SMCs. Under unbalanced stresses, these cells can regulate collagen dynamics by cross-linking and synthesizing new collagen and degrading old collagen [12, 13] . Collagen exposure to cyclic mechanical stretch and sustained hemodynamic stress on the vascular wall leads to reconstitution and degeneration of the ECM. ECM abnormalities play key roles in reducing the resistance of the arterial wall and result in aneurysm enlargement and rupture. Aneurysm stability is dependent on a balance between aneurysm wall repair and its destruction caused by ECM degeneration and dystrophic collagen turnover [13, 14] . ECM degeneration is mainly induced by inflammatory cytokine secretion and cell infiltration [15] [16] [17] . In our study, aneurysms and STA samples were collected. KEGG analysis following label-free quantitative proteomic analysis showed that the focal adhesion and ECM-receptor interaction pathways were strongly correlated with aneurysm progression.
Collagen types IV and VI expression decreased due to CMS, which was also observed in our IHC results. Collagen dysfunction in arterial walls has been reported to cause familial aneurysms [18] [19] [20] . Changes in the collagen type 4 alpha 1 and alpha 2 subunits (COL4A1 and COL4A2) are also related to cerebral vascular disease [21, 22] . The distribution of collagen type IV around SMCs depends on the SMC population and density. Previous studies indicated that collagen type IV was sparsely distributed in aneurysm tissue [23] . Collagen type VI strengthens the aneurysm wall against hemodynamic stress, and decreased collagen type VI expression may be related to the aneurysm growth. Previous studies demonstrated that collagen in situ could be used for aneurysm growth risk assessment, and radio-carbon birth dating of collagen was used as an indicator for molecular changes [24, 25] .
SMCs play a crucial role during aneurysm growth. Mandelbaum et al. found that SMCs contributed to inflammatory cytokine production during aneurysmal lesion development triggered by hemodynamics [26] . Additionally, SMC synthesize collagen and maintain vessel wall impairment and repair under a mechanical load. Mural SMC loss was observed in ruptured aneurysm samples and animal models, indicating that SMCs were important in the resistance to hemodynamic and mechanical stretch [27] . In animal models, medial SMC apoptosis was found at the sites where aneurysms formed under non-physiological flow conditions [28] [29] [30] . SMC apoptosis is at least partially induced by inflammatory cells [31] [32] [33] . Mural SMCs were identified as the sources of MMP-1 and MMP-3, which were correlated with aneurysm collagen content and promoted aneurysm formation [34, 35] . In our study, we demonstrated that CMS directly reduced SMC viability and migration and decreased collagen types IV and VI synthesis under nonphysical flow conditions. Additionally, CMS elevated MMP-1 and MMP-3 expression in HBVSMCs. To improve the ability of SMCs to avoid aneurysm growth, an alternative to the transplantation of SMCs at aneurysm sites was proposed. In animal models, the local transplantation of SMCs into the abdominal aorta aneurysm wall has been shown to stop aneurysm growth [36] . In an extracranial carotid artery embolized aneurysm model, direct transplantation of SMCs led to improved neointimal tissue [37] . However, transplantation of bone SMCs into true intracranial aneurysms has not been reported. The decreased expression of collagen types IV and VI make them useful as markers of aneurysm growth. In one such study, radio-carbon birth dating of collagen type I, which is the main molecular constituent of aneurysms, was used as an indicator of molecular change [24] .
Conclusion
The interaction between CMS and the cerebral arteries is mediated by several cell-tocell interactions and molecular pathways. In our study, we found that the focal adhesion and ECM pathways were changed significantly in the aneurysm samples compared to those in the STA samples via proteomics analysis and observed that the levels of both collagen types IV and VI were decreased. We also identified focal adhesion and ECM alterations in HBVSMCs subjected to15%CMS in vitro. This stretch also reduced collagen types IV and VI expression and increased MMP-1 and MMP-3 expression. This finding may shed light on the biological processes activated by CMS and the possible mechanisms that lead to intracranial aneurysm growth and rupture. It may also provide an additional therapeutic target to prevent the growth of cerebral aneurysms.
Abbreviations
CMS (cyclic mechanical stretch); HBVSMC (human brain vascular smooth muscle cell); KEGG (Kyoto Encyclopedia of Genes and Genomes (http://www.genome.jp/kegg/)); STA (superficial temporal artery).
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